These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7181414)

  • 1. [2 cases of malignant arterial hypertension in hemodialysed children, treated with hemofiltration].
    Fischbach M; Schohn D; Jahn H; Geisert J
    Ann Pediatr (Paris); 1982 Nov; 29(9):666. PubMed ID: 7181414
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant hypertension in a haemodialysis patient treated by ultrafiltration.
    Ok E; Akcicek F; Dorhout Mees EJ; Basci A; Mir S; Kursat S; Unsal A
    Nephrol Dial Transplant; 1995 Nov; 10(11):2124-5. PubMed ID: 8643182
    [No Abstract]   [Full Text] [Related]  

  • 3. "Malignant" intradialytic hypertension: a severe form of intradialytic hypertension.
    Fourtounas C
    Am J Kidney Dis; 2010 Aug; 56(2):418; author reply 418-9. PubMed ID: 20659627
    [No Abstract]   [Full Text] [Related]  

  • 4. [Trial treatment of malignant arterial hypertension by selective renal arterial embolization in 2 patients treated by hemodialysis].
    Merland JJ; Rottembourg J; Thibault P; Jardin A; Glaser P; Jacobs C
    Ann Med Interne (Paris); 1977 May; 128(5):431-5. PubMed ID: 907256
    [No Abstract]   [Full Text] [Related]  

  • 5. [Late ophthalmoscopic changes in patients after malignant hypertension].
    Dróbecka-Brydak E; Swituła M; Brydak-Godowska J; Posepna A; Rancewicz Z; Nowacka-Cieciura E
    Klin Oczna; 1998; 100(1):31-3. PubMed ID: 9685796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of extracorporeal methods of purifying the blood in the combined treatment of patients with symptomatic renal artery hypertension with a stable and with a malignant course].
    Zaruba AIu; Legkonogov AV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):111-2. PubMed ID: 3801129
    [No Abstract]   [Full Text] [Related]  

  • 7. [Malignant arterial hypertension. Current data apropos of 55 cases].
    Guédon J; Lucsko M; Schifrine F; Wajcner G; Legrain M
    Ann Med Interne (Paris); 1972 May; 123(5):437-48. PubMed ID: 5081507
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemofiltration: present and future].
    Bosticardo GM; Triolo G; Basolo B; Belardi P; Bossi P; Aprato A; Boero R; Roccatello D; Alloatti S; Piccoli G
    Arch Sci Med (Torino); 1981; 138(1):1-10. PubMed ID: 7247698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of low-volume hemofiltration in treating severe arterial hypertension with initial manifestations of renal failure].
    Kutsenko AI; Zaruba AIu; Kukharchuk VV; Arabidze GG; Chuĭkin NA
    Kardiologiia; 1989 Apr; 29(4):31-3. PubMed ID: 2754911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Letter: Hemodialysis in malignant hypertension].
    Orth H; Ritz E
    Dtsch Med Wochenschr; 1975 Mar; 100(13):708. PubMed ID: 1122820
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation in 10 patients of malignant hypertension undergoing dialysis treatment (author's transl)].
    Haruyama T; Shitomi K; Murata T; Abe K
    Nihon Jinzo Gakkai Shi; 1977 Jun; 19(6):455-63. PubMed ID: 926436
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversible renal failure in malignant hypertension.
    Cordingley FT; Jones NF; Wing AJ; Hilton PJ
    Clin Nephrol; 1980 Aug; 14(2):98-103. PubMed ID: 7408261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral nephrectomy as a treatment of malignant hypertension.
    El-Said WM
    Int Urol Nephrol; 1974; 6(3-4):209-16. PubMed ID: 4459310
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical presentation and prognostic factors in accelerated arterial hypertension. Review of 29 cases].
    Pérez Fontán M; Escuín F; Huarte E; Miguel JL; Selgas R; Rodríguez-Carmona A; Torre A; Sánchez Sicilia L
    Med Clin (Barc); 1984 Dec; 83(18):747-51. PubMed ID: 6521537
    [No Abstract]   [Full Text] [Related]  

  • 15. Malignant hypertension in a patient with end of stage renal disease (ESRD) treated by renal transplant.
    Gondal M; Farook K; Moin S; Bano U
    J Coll Physicians Surg Pak; 2007 May; 17(5):286-8. PubMed ID: 17553329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of isolation ultracentrifugation in the combined treatment of heart failure refractory to therapy developing in the presence of severe arterial hypertension with stable and malignant courses].
    Zaruba AIu; Kutsenko AI; Kukharchuk VV; Kotkina TI
    Kardiologiia; 1987 Dec; 27(12):20-3. PubMed ID: 3444205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemofiltration. Experiences with a new alternative treatment in terminal kidney failure].
    Pogglitsch H; Waller J; Pristautz H; Katschnigg H
    Wien Med Wochenschr; 1978; 128(21):680-2. PubMed ID: 726465
    [No Abstract]   [Full Text] [Related]  

  • 18. Reversible acute renal faiure in diffuse scleroderma.
    Ponticelli C; Ambroso G; Graziani G; Rossi E
    Clin Nephrol; 1980 Jun; 13(6):293-5. PubMed ID: 7408249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of an adult patient of tetralogy of Fallot having malignant hyperthermia during surgery].
    Hamanaka S; Hata T; Tsushima Y; Matsumoto M; Fujiwara K; Furukawa H; Kuroki K; Masuda Z
    Kyobu Geka; 1997 Sep; 50(10):879-82. PubMed ID: 9301187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [When is hemofiltration indicated, in the treatment of renal insufficiency? (author's transl)].
    Pogglitsch H
    Acta Med Austriaca; 1980; 7(4-5):144-7. PubMed ID: 7246019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.